Grifols.
Spanish pharmaceutical company
- Reports this week
- 0
- Active events
- 0
- Connections
- 49
What's happening
Earlier this month
One to three months ago
-
Grifols, a plasma therapeutic company, operates in the US, Spain, and Canada, and MarketBeat is reporting on analyst recommendations for the company.Some support2 reports
-
Gilead Sciences and Grifols traded on the NASDAQ stock exchange on September 8, 2026.Some support1 report
-
Health Canada found multiple deficiencies at Grifols sites, leading to a partnership established for collecting plasma for medicine.Some support2 reports2 developments inside
-
Grifols, Canadian Blood Services, and Health Canada are working on a framework for sustainable plasma collection.Some support1 report
-
Ground zero for commercial paid plasma collection in Saskatchewan, facing scrutiny over standards.Some support1 report
-
Kissei partnership drives international sales of TAVALISSE, Rigel received $5 million from Grifols, and VEPPANU received FDA approval.Some support2 reports
-
Norges Bank and Royal Bank of Canada made new investment moves in Grifols.Some support1 report
-
Spanish companies, including Grifols and Técnicas Reunidas, participate in a Bahrain consortium amid geopolitical uncertainty and rising oil prices.Some support1 report
-
Grifols was listed on the Nasdaq stock exchange.Some support2 reports
Gone quiet
No new reports in 90+ days-
BioPharma appoints a new US head and secures US plasma supply, while Grifols reorganizes its operating model.Some support1 report
-
Seeking regulatory approval for a new therapy involving the FDA and Grifols.Some support1 report
-
Grifols and Indra Sistemas maintain operational presences in Spain and Europe.Well supported4 reports
-
Whirlpool, Creative Medical Technology Holdings, and Grifols faced downward revisions to their earnings estimates on July 31, 2025.Some support1 report
-
Neurocrine Biosciences and Grifols are both medical drugs stocks.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Grifols this week
News at the entities that move Grifols most-
Nasdaq StructuralBenzinga reported on Cirrus Logic stock, which is listed on Nasdaq, following a price target cut by Susquehanna.Moves Grifols
-
FDA StructuralNeurogene Inc. developed a gene therapy for Rett syndrome and received FDA agreement for a registrational trial design.Moves Grifols
-
Health Canada StructuralHealth Canada approved revyve Antimicrobial Wound Gel, a product developed by a company, for use.Moves Grifols
-
Roland StructuralMeghan Markle reacts to media scrutiny and a designer, vowing never to wear his clothes again.Moves Grifols
-
Canadian Blood Services OperationalCities in Edmonton and Calgary are mobilizing blood donations as part of regional aid efforts.Moves Grifols
-
Bank of Montreal TransactionalBank of Montreal's head office was noted in Montreal, while Trudeau maintained distance from the business community.Moves Grifols
Connections
The 18 strongest of 49, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Nasdaq Structural
Grifols is formally listed on the Nasdaq stock exchange, establishing a market dependency.
-
FDA Structural
The FDA exercises formal regulatory oversight over Grifols' development and market access applications.
-
Roland Structural
Roland serves as the President of Grifols.
-
Health Canada Structural
Health Canada exercises formal regulatory oversight over Grifols, issuing non-compliance notices and suspending operations.
-
Canadian Blood Services Operational
The entities maintain a high-stakes operational partnership for plasma collection, which is simultaneously facing competitive challenges and calls for contract termination.
-
Norges Bank Transactional
Norges Bank acquired a new financial position in Grifols shares.
-
Bank of Montreal Transactional
Bank of Montreal increased its financial stake in Grifols.
-
Pablo García Structural
Pablo García holds the role of director in Divacons, which is a company that is part of the Grifols corporate structure.
Show all 18 connections
-
Royal Bank of Canada Transactional
Royal Bank of Canada increased its financial stake in Grifols.
-
Stevanato Group Operational
Grifols is actively compared to Stevanato Group based on superior earnings outlook and valuation metrics.
-
Brookfield Transactional
Brookfield was involved in speculation and considered a takeover bid for Grifols.
-
Spain Shared context
Grifols is a company that operates and is headquartered within Spain.
-
Saskatchewan Shared context
Grifols operates plasma clinics within the jurisdiction of Saskatchewan.
-
Catalonia Shared context
Grifols is a company whose establishment is rooted in the region of Catalonia.
-
MarketBeat Mentioned together
MarketBeat provides summarized ratings and financial coverage for Grifols.
-
BioPharma Shared context
Both companies operate within the same highly regulated US life sciences market, specifically regarding plasma supply and operational models.
-
WhiteBox Transactional
WhiteBox decreased its stake in Grifols shares.
-
British Columbia Shared context
Grifols operates within the geographical context of British Columbia, Canada.
History
Events by the month they beganSeptember 2026
3 events- Grifols, a plasma therapeutic company, operates in the US, Spain, and Canada, and MarketBeat is reporting on analyst recommendations for the company.
- Gilead Sciences and Grifols traded on the NASDAQ stock exchange on September 8, 2026.
- Grifols, Canadian Blood Services, and Health Canada are working on a framework for sustainable plasma collection.
August 2026
5 events- Canadian Blood Services faces union calls for contract termination after Health Canada issued a non-compliance rating.
- Ground zero for commercial paid plasma collection in Saskatchewan, facing scrutiny over standards.
- Kissei partnership drives international sales of TAVALISSE, Rigel received $5 million from Grifols, and VEPPANU received FDA approval.
- Norges Bank and Royal Bank of Canada made new investment moves in Grifols.
- Spanish companies, including Grifols and Técnicas Reunidas, participate in a Bahrain consortium amid geopolitical uncertainty and rising oil prices.
July 2026
1 eventShow 1 earlier month
June 2026
6 events- Health Canada found multiple deficiencies at Grifols sites, leading to a partnership established for collecting plasma for medicine.
- Grifols was listed on the Nasdaq stock exchange.
- Seeking regulatory approval for a new therapy involving the FDA and Grifols.
- Grifols and Indra Sistemas maintain operational presences in Spain and Europe.
- Whirlpool, Creative Medical Technology Holdings, and Grifols faced downward revisions to their earnings estimates on July 31, 2025.
- Neurocrine Biosciences and Grifols are both medical drugs stocks.